Europe Continuous Bioprocessing Market by Size, Share, Forecasts, & Trends Analysis

 

Europe Continuous Bioprocessing Market to reach $206.1 million by 2030

Europe Continuous Bioprocessing Market by Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User (Pharmaceuticals, Biotechnology, CROs) - Forecast to 2030,” published by Meticulous Research, the Europe continuous bioprocessing market is expected to grow at a CAGR of 19.1% from 2023 to reach $206.1 million by 2030.

Download Free Report Sample Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5605?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=16-04-2024

Continuous bioprocessing is increasingly being adopted in biopharmaceutical manufacturing due to its agility, flexibility, efficiency, and robustness. This approach streamlines processes by minimizing steps, employing smaller facilities and equipment, and enhancing product quality for real-time release.

Currently, continuous bioprocessing is predominantly utilized in small-scale perfusion. However, its benefits, including cost-effectiveness and product quality, are expected to drive its adoption in large-scale biopharmaceutical production in the forthcoming years. Continuous bioprocessing encompasses various components, including instruments and consumables like filtration, chromatography, centrifugation, bioreactors, incubator/shakers, sterilizers, cell culture media, buffers, and reagents.

The growth of this market is attributed to factors such as recent product launches and advances in the continuous bioprocessing space, gradual adoption of continuous manufacturing, and initiatives supporting the adoption of biopharmaceuticals. Furthermore, the shift towards bioprocessing 4.0 and the rising adoption of personalized medicines are expected to provide significant market growth opportunities.

Browse in depth: https://www.meticulousresearch.com/product/europe-continuous-bioprocessing-market-5605?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=16-04-2024

 

Supportive Government Initiatives Across the European Region to Drive the Market’s Growth

Governments across several European nations are undertaking initiatives to promote the adoption of continuous bioprocessing due to their benefits, such as consistent product quality, enhanced productivity, reduced equipment size, streamlined process flow, and low operating and capital expenses. For instance:

The report also includes an extensive assessment of the key growth strategies adopted by leading market players in the past four years. In recent years, the Europe continuous bioprocessing market has witnessed numerous organic and inorganic strategic developments.

The key players profiled in this market study are 3M Company (U.S.), Cytiva (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Sartorius AG (Germany), Repligen Corporation (U.S.), Eppendorf AG (Germany), Applikon Biotechnology (Netherlands), Pall Corporation (U.S.), Solida Biotech GmBH (Germany), Electrolab Biotech Limited (U.K.), Biowest (France), and Bionet (U.S.).

Download request sample report here: https://www.meticulousresearch.com/request-sample-report/cp_id=5605?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=16-04-2024

Based on application, in 2023, the R&D segment is projected to register a higher CAGR during the forecast period. The growing interest in clinical studies for monoclonal antibodies, gene therapies, and vaccines and the focus on increasing R&D scale through government initiatives support the growth of the R&D segment. For instance, in 2021, the government of Ireland allocated USD 975.2 billion (EUR 869.2 billion) for research and development to software, medical devices, manufacturing, and pharmaceutical companies. Furthermore, in 2021, Medical Research Agency (Poland) launched government funding of USD 73.3 million (PLN 300 million) to produce vaccines in Poland.

Based on geography, the market in Germany is projected to register the highest growth rate during the forecast period (2023-2030). The market growth in Germany is driven by the rise in pharmaceutical exports, government grants, growing immunization efforts, increased funding for biotech and biopharmaceutical firms, and the expansion of production capacities among biopharmaceutical companies to meet the growing demand for biologics.

Quick buy: https://www.meticulousresearch.com/Checkout/86338782?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=16-04-2024

 

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

 

 

Comments

Post a Comment

Popular posts from this blog

Revolutionizing API Testing: The Power of Automation in Software Development

API Testing Automation Solutions are sophisticated tools and frameworks designed to streamline the testing of application programming interfaces (APIs). These solutions ensure APIs function accurately, reliably, and securely by automating repetitive and complex testing processes. By minimizing human error and accelerating development cycles, they help organizations deliver high-quality software efficiently and confidently. Download Sample Report Here : https://qksgroup.com/market-research/market-share-api-testing-automation-solutions-2023-worldwide-4085 Key advantages of these solutions include comprehensive testing capabilities across functional, performance, security, and load testing; seamless integration with CI/CD pipelines and development tools; scalability for extensive testing environments; intuitive user interfaces; advanced reporting and analytics; support for multiple protocols like REST, SOAP, and GraphQL; and strong security testing features to identify vulnerabilitie...
Read more

North America's Dominance in the Continuous Glucose Monitoring Market

  The Continuous Glucose Monitoring (CGM) Market is projected to reach $31.41 billion by 2031, growing at a CAGR of 15.0% from 2024 to 2031. Key drivers of this growth include the increasing prevalence of diabetes, sedentary lifestyles, the advantages of CGM over traditional glucose monitoring methods, and the adoption of CGM by athletes and fitness enthusiasts. Additional factors such as technological advancements, a shift towards personalized healthcare, rising health awareness, and improved accessibility to diabetes care devices in low- and middle-income countries are expected to create significant growth opportunities for CGM market players. Download free sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5960?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=08-08-2024 Market Growth Drivers Increasing Prevalence of Diabetes Continuous glucose monitors measure glucose levels and transmit readings to healthcar...
Read more

Cloud Data Warehouses: The Key to Scalable and Agile Data Management

  The growing need for cloud data warehouses stems from the rapid expansion of data generated by modern businesses. Traditional on-premises data warehouses are struggling to keep up with the sheer volume and complexity of this data, creating a demand for more scalable, flexible, and cost-effective solutions. Cloud data warehouses provide an ideal alternative by offering platforms that can efficiently manage structured, semi-structured, and unstructured data while eliminating the limitations of physical infrastructure. These solutions provide virtually limitless storage and processing power, allowing businesses to scale their data operations seamlessly. One of the key advantages of cloud data warehouses is their cost-effectiveness. Unlike traditional data storage systems, which require substantial upfront investments in hardware and ongoing maintenance costs, cloud data warehouses operate on a pay-as-you-go pricing model. This means organizations only pay for the storage and comp...
Read more